Drosophila RET contains an active tyrosine kinase and elicits neurotrophic activities in mammalian cells  by Abrescia, Chiara et al.
FEBS 29701 FEBS Letters 579 (2005) 3789–3796Drosophila RET contains an active tyrosine kinase and
elicits neurotrophic activities in mammalian cells
Chiara Abrescia, Dan Sjo¨strand, Svend Kjaer1, Carlos F. Iba´n˜ez*
Division of Molecular Neurobiology, Department of Neuroscience, Karolinska Institute, S-171 77 Stockholm, Sweden
Received 25 February 2005; revised 21 May 2005; accepted 30 May 2005
Available online 14 June 2005
Edited by Jesus AvilaAbstract The RET receptor tyrosine kinase controls kidney
organogenesis and development of subpopulations of enteric
and sensory neurons in diﬀerent vertebrate species, including
humans, rodents, chicken and zebraﬁsh. RET is activated by
binding to a ligand complex formed by a member of the glial cell
line-derived neurotrophic factor (GDNF) family of neurotrophic
factors bound to its cognate GFRa GPI-linked co-receptor. De-
spite the absence of GDNF or GFRa molecules in the Drosophila
genome, a RET orthologue (dRET) has recently been described
in this organism and shown to be expressed in subpopulations of
cells of the excretory, digestive and nervous systems, thus resem-
bling the expression pattern of RET in vertebrates. In this study,
we report on the initial biochemical and functional characteriza-
tion of the dRET protein in cell culture systems. Full-length
dRET could be produced in mammalian and insect cells. Similar
to its human counterpart (hRET), overexpression of dRET re-
sulted in its ligand-independent tyrosine phosphorylation, indi-
cating that it bears an active tyrosine kinase. Unlike hRET,
however, the extracellular domain of dRET was unable to inter-
act with mammalian GDNF and GFRa1. Self association be-
tween dRET molecules could neither be detected, indicating
that dRET is incapable of mediating cell adhesion by homophilic
interactions. A chimeric molecule comprising the extracellular
domain of hRET and the kinase domain of dRET was con-
structed and used to probe ligand-mediated downstream activi-
ties of the dRET kinase in PC12 cells. GDNF stimulation of
cells transfected with the hRET/dRET chimera resulted in neu-
rite outgrowth comparable to that obtained after transfection
of wild-type hRET. These results indicate signiﬁcant conserva-
tion between the biological eﬀects elicited by the human and Dro-
sophila RET kinases, and suggest functions for dRET in
neuronal diﬀerentiation in the ﬂy.
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The ret gene was originally identiﬁed as a human oncogene
in cellular transformation assays [1]. Subsequent studies re-
vealed this gene to encode a phylogenetically conserved recep-
tor tyrosine kinase, consisting of an extracellular domain, a
single-pass transmembrane domain and a typical intracellular
tyrosine kinase domain (reviewed in [2]). The extracellular do-
main of mammalian RET binds soluble ligands belonging to
the glial cell line-derived neurotrophic factor (GDNF) family
in collaboration with glycosyl phosphatidylinositol (GPI) an-
chored co-receptors known as GFRa proteins. Upon activa-
tion in this complex, RET is thought to form active
homodimers that undergo autophosphorylation of speciﬁc
tyrosine residues in the cytoplasmic domain, leading to down-
stream signaling [3–5]. During mammalian embryogenesis,
RET signaling plays a critical role in determining survival
and diﬀerentiation of many subpopulations of neurons origi-
nating from the neural crest, as well as in kidney morphogen-
esis [2,6]. Both loss of function and gain of function mutations
in the ret gene have been associated to human diseases. Het-
erozygous loss-of-function mutations lead to Hirschprung dis-
ease, a hereditary developmental disorder characterized by
aganglionosis of the distal part of the intestinal tract [2,7].
On the other hand, activating mutations are associated with
multiple endocrine neoplasias MEN2A and MEN2B, medul-
lary thyroid carcinomas (MTC) and pheochromocytomas
[2,7,8]. Only one RET paralogue gene has been found in all
species investigated so far, and alignments of RET sequences
from several vertebrate species and from Drosophila melano-
gaster have revealed phylogenetic relationships between RET
orthologues of diﬀerent metazoan species [9]. Intriguingly, in
the developing chick, zebraﬁsh and in Drosophila, RET
mRNA has been localized in cells that are functionally equiv-
alent to RET-expressing cells in developing mammalian em-
bryos, including portions of the nervous, excretory and
digestive systems [10–13], suggesting a signiﬁcant degree of
functional conservation across species.
The tyrosine kinase domain is the most conserved portion of
RET, with up to 90% of sequence identity within the vertebrate
lineage and overall 65% sequence identity between seven verte-
brate species and Drosophila [9,13]. The high degree of homol-
ogy of the catalytic core of the kinase between vertebrate and
invertebrate species suggests that Drosophila RET (herein
dRET, also reported as sequence CG14396, FlyBase ID:
Fbgn0011829) is an active tyrosine kinase [14], and may there-
fore exert functions similar to human RET (herein hRET) with
regards to downstream signaling. Although the extracellularblished by Elsevier B.V. All rights reserved.
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among vertebrate RET species), it contains highly homologous
structural motifs which unequivocally identify RET as a un-
ique receptor tyrosine kinase in those species [9,13,14]. One
such element is the cysteine-rich domain (CRD). Cysteine res-
idues in this region of RET are believed to be involved in intra-
molecular disulphide bridges, which are important for the
tertiary structure of the molecule [7]. Fourteen of the 28 cys-
teine residues within this domain are conserved between hu-
man, zebraﬁsh and Drosophila RET molecules [13]. MEN2A
and familial MTC syndromes are associated with mutations
of one out of 6 conserved cysteine residues in the CRD of hu-
man RET (positions 609, 611, 618, 620, 630 and 634, respec-
tively). These mutations lead to aberrant intermolecular
disulphide bonds between RET molecules, dimerization and
subsequent constitutive activation of receptor kinase activity
[7]. Another characteristic feature of the extracellular domain
of RET is the presence of four cadherin-like domains (CLDs)
[9]. Cadherins are Ca2+-dependent cell–cell adhesion proteins
and their adhesive properties depend on a domain of 110 ami-
no acids repeated in tandem in their extracellular region. The
presence of four phylogenetically conserved CLDs in the extra-
cellular region of RET has prompted its classiﬁcation within
the cadherin superfamily [15,16], although no cell adhesion
activity has been demonstrated so far for RET molecules.
RET has a role in the transduction of signals from all ligands
belonging to the GDNF family identiﬁed in vertebrates and its
function is not genetically redundant. Moreover, the expres-
sion pattern of the Drosophila RET gene, as determined by
whole mount in situ hybridization of Drosophila embryos,
strongly suggests a function of dRET in triggering develop-
mental signals analogous to those exerted in mammalian
embryogenesis [2,6,12,13]. Nonetheless, neither GDNF family
ligands nor GFRa co-receptors can be found in the Drosophila
genome [17,18]. Thus, it is not yet understood whether humanFig. 1. Full-length dRET is correctly folded and phosphorylated in mammali
full-length dRET C-terminally tagged with a c-myc epitope (dRET-myc) in
running at about 200 kDa. Proteolytically cleaved dRET products were also
(B) EndoH digestion conﬁrms correct folding of the upper dRET in the 200 kD
is a folding intermediate retained in the endoplasmic reticulum (see [20]).
spontaneous tyrosine phosphorylation of dRET after overexpression in COSand Drosophila RET are functionally related nor which are the
counterparts of the mammalian system in Drosophila. The
paucity in our understanding of the functional properties of
dRET is underscored by the absence of mutant alleles of the
dRET locus in the FlyBase database. In the present work,
we have characterized the expression of dRET in cultured cells
and investigated its biochemical and biological functions in
vitro in comparison with hRET.2. Results
2.1. Full-length dRET is correctly folded and phosphorylated in
mammalian cells
As a ﬁrst step to investigate functional properties of full-
length dRET, we generated constructs containing the full
length dRET cDNA (classiﬁed as CG14396 in the FlyBase
database) fused to a C-terminal myc tag for overexpression
in mammalian and insect cells. Cell lysates were analyzed by
immunoprecipitation with anti-myc antibodies, followed by
immunoblotting with antibodies (panRET) directed against a
peptide sequence in the activation loop of the RET kinase that
is highly conserved between mammalian and Drosophila RET
proteins. Full-length dRET was consistently expressed at lower
levels in either mammalian or insect cells, and required pooling
of several conﬂuent plates for immunodetection in cell lysates.
Although the calculated molecular weight of the dRET poly-
peptide was deduced to be around 140 kDa, full-length dRET
was expected to migrate slower due to N-glycosylation at eight
predicted sites. dRET expressed in mammalian cells appeared
primarily as two bands migrating with a molecular weight of
approximately 200 kDa in SDS/PAGE, that were likely to rep-
resent full-length dRET (Fig. 1A). Additional products were
also observed at 120 and 60 kDa (Fig. 1A), which may have
arisen by endoproteolytic cleavage of dRET. dRET bands ofan cells. (A) Immunoprecipitation (IP) and immunoblot (IB) analysis of
COS cells. Arrow indicates full-length, correctly folded dRET protein
observed running at 120 and 60 kDa, respectively (open arrowheads).
a doublet, and indicates that the lower, EndoH-sensitive band (arrow)
(C) Immunoblotting with anti-phosphotyrosine antibodies revealed
cells. Full-length dRET is indicated with an arrow.
C. Abrescia et al. / FEBS Letters 579 (2005) 3789–3796 3791200, 120 and 60 kDa were also observed upon expression of
dRET in Drosophila Schneiders 2 cells (data not shown), sug-
gesting an intrinsic propensity of dRET to proteolytic cleavage
independently of cell type. The fact that dRET fragments of 60
and 120 kDA retained the C-terminal myc tag, together with
their apparent molecular weights, pointed to extracellular
and/or transmembrane cleavage sites. However, treatment of
dRET-expressing cells with the c-secretase inhibitor
L-685,458 [19] had no eﬀect on the proﬁle of dRET products
detected in cell lysates (data not shown). Similar to previous
observations with hRET [20], only the upper band of the
200 kDa dRET doublet was resistant to treatment with endo-
glycosidase H (EndoH) (Fig. 1B), indicating that it represented
mature, correctly folded, plasma membrane dRET. EndoH
cleaves oﬀ carbohydrates from glycoproteins which are at the
stage of folding intermediates and present in the endoplasmic
reticulum (ER). Correctly folded glycoproteins loose sensitivity
to EndoH treatment as carbohydrates of higher complexity are
added in the Golgi. As with hRET, the lower, EndoH-sensitive
band in the doublet (arrow in Fig. 1B) was likely to represent
immature, partially glycosylated dRET retained in the ER.
Similar to other receptor tyrosine kinases (e.g. [21]), overex-
pression of dRET in mammalian cells resulted in ligand-inde-
pendent tyrosine phosphorylation (Fig. 1C). This was likely
due to autophosphorylation, as overexpressed kinase-dead mu-
tants of RET proteins do not show tyrosine phosphorylation
(data not shown). Intriguingly, tyrosine phosphorylation was
observed in all three dRET fragments, suggesting that they
all contain an active tyrosine kinase.
2.2. Expression and functional analysis of the extracellular
domain of dRET
In order to analyze dRET functions, we ﬁrst generated sev-
eral mammalian expression plasmids encoding a soluble form
of the extracellular domain of dRET (herein dRETECD) alter-
natively fused to diﬀerent C-terminal tags, such as c-myc,
human Fc and hemagglutinin (HA) epitopes. Upon
overexpression of the dRETECD in COS cells, we tested the
correct folding and post-translational modiﬁcation of the se-
creted product by EndoH and peptide:N glycosidase F (PNG-
aseF) digestion assays as described above. We performed
EndoH and PNGaseF digestions on equivalent amounts of
conditioned medium harvested from COS7 cells overexpress-
ing HA-tagged dRETECD, and subsequently detected the prod-
ucts by Western blotting with antibodies directed against the
C-terminal HA tag. The band migrating at a molecular weight
of about 120 kDa corresponds to the expected size of the fully
glycosylated dRETECD. The protein was resistant to EndoH
and sensitive to PNGaseF digestion, indicating that it was se-
creted from COS cells as a fully mature polypeptide (Fig. 2A).
COS cell conditioned medium containing dRETECD was then
used to probe the ability of this protein to interact with mam-
malian GDNF and GFRa1 in an ELISA binding assay. HA-
tagged dRETECD was allowed to bind to a solid support that
had previously been coated with anti-HA antibodies, and
GDNF was subsequently added along with a puriﬁed soluble
form of GFRa1 fused to a fragment of human IgG heavy
chain (GFRa1-Fc). The amount of GFRa1-Fc retained on
the support through binding to GDNF and dRETECD was
then quantiﬁed using a second anti-Fc antibody, and com-
pared to negative (blank) and positive (hRETECD) controls.
Unlike its human counterpart, the dRETECD was unable toform a complex with mammalian GDNF and GFRa1 (Fig.
2B). In order to investigate whether membrane bound dRET
could bind mammalian GDNF in the presence of GFRa1,
we transfected hRET or dRET together with GFRa1 in
COS cells and tested the ability of RET molecules to interact
with radiolabeled GDNF (125I-GDNF) by chemical cross-linking
and immunoprecipitation. This experiment showed that COS
cell-expressed hRET, but not dRET, was able to bind GDNF
in the presence of GFR a1 (Fig. 2C), indicating that the Dro-
sophila receptor is unable to interact with mammalian GDNF
ligands.
All RET orthologues identiﬁed so far are likely to be phylo-
genetically related, not only by the high degree of sequence
identity of the tyrosine kinase domain, but also by the presence
of homologous cadherin-like domains in their extracellular re-
gions [9,13]. Given that cadherins have cell adhesion functions,
we investigated the possibility that the dRETECD may be able
to mediate cell adhesion. In the ﬁrst set of experiments, we ad-
dressed this in vitro by combining equivalent amounts of two
diﬀerentially tagged soluble ECD constructs, immunoprecipi-
tating the mixture with antibodies directed against either of
the two tags, and performing Western blot analysis against
the second tag. A similar experiment was also performed using
supernatants of COS cells that had been simultaneously co-
transfected with the two ECD constructs. Previous studies
have shown that bonaﬁde cell adhesion molecules are able to
engage in homologous interactions in solution (e.g. [22]). How-
ever, no co-immunoprecipitation of the two tagged dRETECD
proteins could be detected in either system (data not shown),
indicating that the dRETECD is not capable of self associating
in vitro. In a second set of experiments, we tested the ability of
dRET to mediate cell adhesion directly in transfected Jurkat
cells. Two days after transfection together with a GFP ﬂuores-
cent protein reporter, cells that received an expression con-
struct of the neural cell adhesion molecule NCAM formed
clusters of 2–20 cells, indicating NCAM-mediated cell adhe-
sion (Fig. 2D). On the other hand, control transfected cells
remained as a dispersed cell suspension. In contrast to
NCAM-transfected cells, no clusters were observed in cells
that received dRET (Fig. 2D), indicating that dRET is unable
to mediate cell adhesion in this assay.
2.3. The dRET kinase domain can mediate ligand-dependent
neuronal diﬀerentiation of PC12 cells
In order to characterize the functional capabilities of the ki-
nase domain of dRET, and in the absence of cognate dRET
ligands, we generated a chimeric molecule consisting of the
extracellular and transmembrane regions of human RET fused
to the kinase domain of Drosophila RET (herein termed hRE-
TECD/dRETKIN) (Fig. 3A). A similar approach – albeit using
the ectodomain of the human EGF receptor – has previously
been used to functionally characterize the hRET receptor prior
to the discovery of its endogenous ligands [23]. We speculated
that activation of such chimeric molecule by GDNF and
GFRa1 should allow us to evaluate the functional output of
the dRET kinase domain. After overexpression in COS cells,
the hRETECD/dRETKIN chimera could be detected by immu-
noblotting with an apparent molecular weight similar to that
of dRET (Fig. 3B). A kinase dead chimeric construct carrying
a substitution of Lys-805 into Met (h/dRETK805M) was
also generated. Wild type dRET and hRET as well as the
hRETECD/dRETKIN chimera showed high levels of Tyr
Fig. 2. dRET does not bind to the GDNF/GFRa1 complex of mammalian origin and nor does it mediate cell adhesion. (A) Soluble dRETECD from
COS cell conditioned medium was digested with the indicated glycosidases as previously described [20], and subsequently analyzed by
immunoblotting (IB) with antibodies against the C-terminal HA tag. dRETECD was resistant to EndoH digestion and therefore correctly folded.
Negative (control) and positive (PNGaseF) control digestions are shown. (B) Solid phase binding assay of mammalian GDNF and GFRa1 to human
and Drosophila RETECD proteins. Signiﬁcant binding was only observed using hRET. No binding above background could be observed with
dRETECD. (C) Chemical cross-linking of 125I-GDNF in COS cells transfected with GFRa1 and the indicated RET constructs. Mock transfected COS
cells were included as control. Excess unlabeled GDNF (cold) was used to verify the speciﬁcity of the binding. Following ligand binding and cross-
linking, cell lysates were immunoprecipitated with anti-hRET or anti-myc antibodies – as appropriate – and processed by autoradiography after
SDS/PAGE. The bottom panel shows a reprobing with the panRET antibody of the same membrane. (D) Cell adhesion assay in Jurkat cells
transfected with NCAM, dRET or a control construct along with the ﬂuorescence protein marker GFP. Note that cell clusters – indicative of cell
adhesion – can only be seen in cells that received NCAM but not dRET.
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(Fig. 3B). As expected, the kinase dead construct was not
phosphorylated (Fig. 3B), conﬁrming that Tyr phosphoryla-
tion of the dRET kinase requires an activate kinase and is
therefore most likely a consequence of autophosphorylation.
GDNF has been shown to elicit neuronal diﬀerentiation of
the rat pheochromocytoma cell line PC12 expressing RET
and GFRa1 receptors [24,25]. Although PC12 cells do express
low levels of RET endogenously, the eﬀect of GDNF is signif-
icantly more robust after introducing exogenous RET into
these cells. Thus, we overexpressed wild type and chimeric
receptors in PC12 cells by transient transfection together with
a construct encoding green ﬂuorescent protein (GFP) to iden-
tify transfected cells. Immunostaining with the panRET anti-
body showed reactivity in RET-expressing cells coinciding
with GFP expression (Fig. 4A). Negligible background signal
was observed in untransfected cells, indicating too low levels
of endogenous RET expression for detection by the panRET
antibody. Transfected cells were stimulated with GDNF and
soluble GFRa1, and the percentage of diﬀerentiated cells
was assessed in mock-transfected cells as well as cells that re-
ceived either full-length hRET, dRET or the hRETECD/dRETKIN
chimeras. Low levels of ligand-mediated diﬀerentiation wereobserved in cells transfected with a control plasmid (Fig.
4B), a response presumably produced by endogenous RET
receptors present in PC12 cells. On the other hand, transfec-
tion of either hRET, dRET or the hRETECD/dRETKIN chi-
mera induced low levels of ligand-independent diﬀerentiation
(Fig. 4B), probably caused by the spontaneous activation of
overexpressed receptors. Ligand stimulation, however, pro-
duced a robust increase in the percentage of diﬀerentiated cells
(about 5–6-fold) that received hRET or hRETECD/dRETKIN
but not dRET or the kinase dead chimera h/dRETK805M
(Fig. 4B). Importantly, the levels of cell diﬀerentiation
achieved by hRET or the hRETECD/dRETKIN chimera were
comparable. This indicated that the binding of GDNF and sol-
uble GFRa1 to the extracellular portion of hRET was able to
activate neuronal diﬀerentiation pathways in PC12 cells
through the kinase domain of dRET, and suggested signiﬁcant
conservation between the signaling pathways activated by the
two species of RET molecules. In order to test this notion fur-
ther, we investigated the role of the MAP kinase pathway in
the eﬀects of the dRET kinase on PC12 diﬀerentiation. For this
purpose, we used the MEK1 inhibitor PD98059 which blocks
upstream activation of the pathway in PC12 transfected with
wild type and chimeric RET constructs as above. The inhibitor
Fig. 3. Generation of a chimeric hRETECD/dRETKIN receptor. (A) Schematic representation of the hRETECD/dRETKIN chimeric molecule showing
the sequence at the junction between human and Drosophila fragments. The conserved motif (KWEFPR) common to both proteins is highlighted.
ECD, extracellular domain; TM, transmembrane domain, JUX, juxtamembrane domain. (B) Immunoprecipitation (IP) and immunoblot (IB)
analysis of hRETECD/dRETKIN C-terminally tagged with a c-myc epitope in COS cells. hRET and dRET are also shown for comparison. Note lack
of Tyr phosphorylation of the mutant chimera h/dRETK805M.
C. Abrescia et al. / FEBS Letters 579 (2005) 3789–3796 3793dramatically reduced the eﬀects of either the hRET or dRET
kinase in PC12 cells diﬀerentiation (Fig. 4B), indicating that
Drosophila RET, like its human counterpart, utilizes the
MAP kinase pathway to induce neuronal diﬀerentiation.3. Discussion
In this work, we set out to characterize biochemically and
functionally the dRET tyrosine kinase receptor in cell culture
systems. Our ﬁndings support the hypothesis that dRET can
trigger pathways that are to some degree comparable to those
elicited by its human counterpart, and are in line with the pre-
viously suggested similarity between the kinase domains of the
two receptors [9,13], and by the resemblance between the
expression patterns of the two proteins in embryos [10–13].
In addition to the full-length protein, overexpression of
dRET resulted in the appearance of two smaller fragments
both in mammalian and insect cells. The functional signiﬁ-
cance of such cleavage is at present unknown. Protease cleav-
age could represent a strategy to regulate dRET expression at
the post-translational level. In vertebrates, for example, a fold-
ing bottleneck during RET biosynthesis has been proposed to
regulate the levels of RET at the plasma membrane [20]. It is
also possible that endogenous dRET forms part of a larger
complex in vivo, so that cleavage may be inhibited in cells
co-expressing physiological interactors of the receptor. These
possibilities suggest that the regulation of the expression ofthe RET protein in Drosophila might be as complex as in ver-
tebrates. Although hRET has been reported to have pro-apop-
totic activities following caspase cleavage of its intracellular
domain [26], we were not able to detect increased cell death
upon transfection of dRET in mammalian cells (C.A., unpub-
lished observations). Moreover, neither of the two consensus
sites that have been reported to be required for hRET cleavage
by caspase-3, namely VSVD707 and DYLD1017 [26], are con-
served to any signiﬁcant degree in the primary sequence of
dRET. In any case, cleavage of intracellular sequences would
not be able to explain the dRET fragments of 120 and
60 kDa that we detected in transfected cells. Overexpression
of RET in mammalian cells results in autophosphorylation
of tyrosine residues in a ligand-independent manner [27]. The
fact that both human and Drosophila RET showed similar
tyrosine phosphorylation after overexpression suggests they
may share a common mechanism of activation mediated by
receptor dimerization, similar to other receptor tyrosine ki-
nases, and in agreement with the high sequence similarity be-
tween the kinase domains of human and Drosophila RET.
The divergence of the ﬁrst three CLDs of human and Dro-
sophila RET explains the inability of dRET to interact with
the mammalian GDNF/GFRa1 complex, as that region of
the RET receptor has been shown to be involved in ligand
binding [28]. No neurotrophic molecule has to date been iden-
tiﬁed in the Drosophila genome [17,18,29,30], which could be
taken to imply that cognate dRET ligands might be ‘‘non-
neurotrophic’’ signaling factors. On the other hand, this receptor
Fig. 4. The dRET kinase domain can mediate ligand-dependent neuronal diﬀerentiation of PC12 cells. (A) Expression of hRETECD/dRETKIN in
transiently transfected PC12 cells stimulated for three days with GDNF and GFRa1 as analyzed by immunoﬂuorescence with anti-panRET
antibodies (left panel). The middle panel shows GFP expression in the same ﬁeld, conﬁrming that GFP positive cells express the hRETECD/dRETKIN
chimera. Neuritic processes in diﬀerentiated cells are indicated by arrowheads. A merged image is shown to the right. (B) Quantitative analysis of
neuronal diﬀerentiation induced by GDNF and soluble GFRa1 in PC12 cells transiently transfected with the indicated constructs. The number of
GFP positive cells bearing neuritic processes longer than two cell diameters were counted and expressed as percentage of the total number of GFP-
expressing cells. The MEK1 inhibitor PD98059 was used at 50 lM as indicated.
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the control of cell survival has been shown to be dependent on
trophic support from target-derived molecules [30,31]. Despite
their sequence divergence, the presence of CLDs across meta-
zoan RET molecules identiﬁed suggested that these domains
might have mediated cell adhesion functions in ancestral
RET-like molecules, prior to the appearance of GDNF li-
gands. However, our combined in vitro association analyses
with the dRETECD and cell adhesion assays in Jurkat cells gave
no indication that such activity is present in the dRET mole-
cule.
It has been reported that a number of eukaryotic genes orig-
inally annotated as kinases based on sequence homologies
actually correspond to pseudogenes and do not encode enzi-
matically active kinases [14]. Although cognate ligands of
dRET are presently unknown, our analysis of the hRETECD/
dRETKIN chimera conﬁrmed that the intracellular portion of
the dRET receptor features an active kinase, and indicated
that the dRET kinase domain may be activated in a ligand-
dependent manner. The ability of the dRET kinase to mediate
ligand-dependent neuronal diﬀerentiation of PC12 cells to a
similar extent than hRET indicated a certain degree of conser-
vation of functional and biochemical properties of the tworeceptors. In agreement with this, both kinases required the
MAP kinase pathway to induce neuronal diﬀerentiation in
PC12 cells. The expression of dRET in sensory neurons of
the ﬂy suggests that pathways activated by this receptor may
contribute to the diﬀerentiation of these cells. In this context,
identiﬁcation of endogenous dRET ligands may contribute
to elucidate novel mechanisms of developmental regulation
of specialized cell types in the ﬂy.
In conclusion, our ﬁndings reinforce the hypothesis of an
evolutionary link between human and Drosophila RET, not
only from a structural point of view, but also based on the
functional analysis of the dRET protein. In addition, the bio-
chemical tools developed in this study may help to identify the
endogenous ligand(s) of dRET and further our understanding
of the physiological roles of this protein at the molecular level.4. Materials and methods
4.1. Plasmid constructs
The LCL12 plasmid containing a full-length dRET cDNA was a
kind gift from Dr. Michael Bishop (UCSF, San Francisco). The
dRETECD was isolated from this plasmid by PCR and subcloned in
a modiﬁed pSec-Tag2A mammalian expression vector (Invitrogen)
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hRETECD has been described elsewhere [20]. Full-length dRET expres-
sion plasmids were constructed using expression vectors for insect
(pIB-V5HIS, Invitrogen) or mammalian (pCDNA3, Invitrogen) cells
and a dRET cDNA ampliﬁed from LCL12. Full-length hRET plasmid
(long isoform) has been described elsewhere [32] (see Fig. 3A). In order
to generate the hRETECD/dRETKIN chimeric construct, a fragment
corresponding to the dRET kinase domain ﬂanked by a C-terminal
myc tag was ampliﬁed by PCR and subcloned into the corresponding
position of the hRET cDNA (see Fig. 3A for details). The K805M
mutation was introduced in the wild-type sequence of the intracellular
domain of dRET by site-directed mutagenesis. All constructs were ver-
iﬁed by automated DNA sequencing. Enhanced green ﬂuorescence
plasmid (GFP) was from Clontech.4.2. Cell culture, transfection, immunoﬂuorescence and cell adhesion
assay
Drosophila Schneiders 2 (SL2) and mammalian cells were cultured
under standard conditions and transfected with Fugene6 (Roche)
according to the manufacturers instructions. PC12 cells growing on
PDL-coated 48-well plates that had been diﬀerentiated for 3–4 days
with GDNF (50 ng/ml) and GFRa1-Fc (150 ng/ml) were ﬁxed in 4%
paraformaldehyde in PBS, washed, permeabilized with 0.1% Triton
X-100 and blocked with 1% Goat serum. They were then incubated
with primary antibody (panRET anti-Y905 or anti-myc) and washed
before addition of biotin-SP conjugated anti-mouse antibody (Jackson
Immunoresearch). The reaction was then developed with Cy3-conju-
gated streptavidin (Jackson Immunoresearch) and visualized with an
inverted ﬂuorescence microscope. Cell adhesion assays in transiently
transfected Jurkat cells were performed as previously described [33].4.3. Expression of soluble dRETECD and in vitro binding assay
COS cells were transiently transfected with the dRETECD pSec-
Tag2A plasmid and, 24 h after transfection, complete medium was re-
placed by serum-free medium as previously described [20]. At this time,
cultures were moved to 30 C to enhance production yields [20] and left
for 3–4 days. Conditioned medium was concentrated by ultraﬁltration
(Amicon) and protein concentration was normalized by immunoblot-
ting with HA antibodies. hRETECD was produced, puriﬁed and nor-
malized in the same way following previously published procedures
[20]. In order to assess binding of RETECD constructs to the GDNF/
GFRa1 complex, a solid-phase immunosorbent assay was utilized as
previously described [20]. Brieﬂy, blocked ELISA wells were coated
with anti-HA antibodies (Covance) and HA-tagged RETECD proteins
were added. The samples were then washed, and subsequently a com-
plex of GDNF and Fc-tagged GFRa1 was added. After washing, the
reaction was developed with goat anti-human Fc antiserum, HRP-con-
jugated anti-goat antibodies (Jackson Immunoresearch), and the
3,3 0,5,5 0-tetramethyl benzidine (TMB) substrate according to the
instructions of the manufacturer (Pierce).4.4. Immunoprecipitation, immunoblotting, deglycosylation and chemical
cross-linking assays
Immunoprecipitations and immunoblottings were performed as pre-
viously described [20] using antibodies as follows: anti-myc, anti-phos-
photyrosine (PY99) from Santa Cruz Biotechnology; anti-HA from
Covance Biosite, anti-panRET (Y905) monoclonal was kindly pro-
vided by Anatoly Sharipo (University of Latvia, Riga). All blots were
developed with enhanced chemiﬂuorescence (Amersham Biosciences),
scanned in a Storm 840 (Molecular Dynamics) and analyzed with
ImageQuant software. For deglycosylation assays, immunoprecipitates
were eluted by boiling in glycosidase denaturing buﬀer (New England
Biolabs), EndoH or PNGaseF digestion buﬀer was added to the sam-
ples, and digestions with either EndoH or PNGaseF were performed
according to the instructions of the manufacturer (New England Bio-
labs). Soluble dRETECD contained in the conditioned medium har-
vested from transiently transfected COS cells was assayed as
described [20]. GDNF was radioiodinated by the lactoperoxidase
method. Chemical cross-linking assays in transfected COS cells were
performed with 20 ng/ml 125I-GDNF in the presence or absence of
500-fold excess unlabeled (cold) GDNF using EDAC and Sulfo-
NHS as previously described [33].4.5. PC12 diﬀerentiation assay
Twelve hours after transfection, PC12 cells growing on PDL-coated
48-well plates were transferred to serum-free medium, left for 24 h, and
then stimulated with GDNF (80 ng/ml) and GFRa1-Fc (140 ng/ml) in
medium supplemented with 0.5% fetal calf and 1% horse serum. For
the MAP kinase pathway inhibition experiments, the MEK1 inhibitor
PD98059 (Sigma) was used to a ﬁnal concentration of 50 lM. After 3–
4 days, the number of GFP expressing cells was determined in 10 dif-
ferent ﬁelds, and the fraction of cells displaying a neurite longer than
two cell diameters was calculated. At least three independent determi-
nations were performed after transient transfection of each construct,
and in each experiment values were assessed in 3–6 duplicates per sam-
ple. Levels of expression of hRET, dRET or the hRETECD/dRETKIN
chimera were conﬁrmed by immunoﬂuorescence as described above.
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